Author = Rabah Ahmed Taha Serya
AML and FLT3: An update on FDA-approved or under review kinase inhibitors targeting FLT3 kinase

Articles in Press, Accepted Manuscript, Available Online from 29 October 2023

10.21608/ejchem.2023.231603.8488

Nada Alaa El-Deen; Eman M.E. Dokla; Mai Youssef Jaballah; Khaled Abouzid; Rabah Ahmed Serya


Hit Identification Against Candida Albicans: Design, Synthesis, Molecular Docking and Biological Evaluation of Hybrid Styryl-Quinoxaline Based Analogues.

Volume 66, Issue 13, December 2023, Pages 1295-1308

10.21608/ejchem.2023.205360.7850

Aliya Mohamed shaker El Newahie; Maiy Y. Jaballah; Mohamed Alaraby; Mohamed elbadawy; Rabah Ahmed Serya; Aliaa mohamed Kamal; Khaled Abouzid


Synthesis, Biological Evaluation and In Silico Investigation of Novel Functionalized Imidazole-Based KDM6 Inhibitors

Volume 64, Issue 3, March 2021, Pages 1575-1582

10.21608/ejchem.2020.38209.2790

Amr Mostafa El-Araby; Omar Magdy Qassem; Ezzat Ashraf El-Sawy; Eman Zaghlol El-Razaz; Khaled Abouzid; Rabah Ahmed Taha Serya